tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

ANI Pharmaceuticals Inc

ANIP
Add to Watchlist
79.240USD
-1.190-1.48%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.80BMarket Cap
19.26P/E TTM

ANI Pharmaceuticals Inc

79.240
-1.190-1.48%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

ANIP Financials

See ANI Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

ANI Pharmaceuticals Inc Earnings Date

Latest Release
Aug 7, 2026
EPS / Forecast
--/2.05
Revenue / Forecast
--/260.13M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
883.37M
43.78%
EPS(YoY)
3.50
435.75%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
87.55%1.31
323.36%1.23
193.59%1.19
364.80%0.37
-16.51%0.70
-1594.26%-0.55
-376.67%-1.27
-146.99%-0.14
1392.39%0.84
112.91%0.04
--0.46
--0.30
--0.06
---0.28
---2.76
----
----
----
----
----
Revenue
20.46%237.46M
29.64%247.06M
53.58%227.81M
53.12%211.37M
43.43%197.12M
44.75%190.57M
12.52%148.33M
18.44%138.04M
28.70%137.43M
39.71%131.65M
57.27%131.83M
57.81%116.55M
65.62%106.79M
54.66%94.23M
61.01%83.82M
51.89%73.86M
18.26%64.48M
6.42%60.93M
-1.73%52.06M
0.32%48.63M
Net Profit
100.05%27.43M
337.66%25.39M
196.82%23.79M
371.83%7.32M
-14.28%13.71M
-1628.18%-10.68M
-384.30%-24.57M
-151.32%-2.69M
1638.70%16.00M
115.03%699.00K
195.97%8.64M
134.24%5.25M
104.48%920.00K
80.88%-4.65M
-102.52%-9.01M
-8.68%-15.33M
-23977.91%-20.54M
-569.22%-24.33M
-1153.79%-4.45M
-14.35%-14.11M
Net Margin
56.12%12.42%
306.35%11.13%
171.72%11.68%
344.12%4.04%
-39.95%7.95%
-714.63%-5.39%
-316.07%-16.29%
-130.92%-1.66%
883.13%13.25%
119.48%0.88%
--7.54%
--5.36%
--1.35%
---4.50%
---19.65%
----
----
----
----
----
Gross Margin
0.87%51.78%
9.23%50.26%
4.72%49.07%
12.89%53.69%
-4.13%51.34%
-3.90%46.02%
-9.84%46.86%
-6.96%47.56%
5.15%53.55%
3.91%47.88%
--51.98%
--51.12%
--50.92%
--46.08%
--34.75%
----
----
----
----
----
Debt to assets ratio
-10.43%43.16%
-11.94%42.85%
-9.32%44.05%
49.39%46.28%
54.39%48.19%
54.05%48.66%
51.21%48.58%
-6.95%30.98%
-16.57%31.21%
-16.21%31.59%
--32.12%
--33.29%
--37.41%
--37.70%
--38.79%
----
----
----
----
----
Income Statement
Revenue
20.46%237.46M
29.64%247.06M
53.58%227.81M
53.12%211.37M
43.43%197.12M
44.75%190.57M
12.52%148.33M
18.44%138.04M
28.70%137.43M
39.71%131.65M
57.27%131.83M
57.81%116.55M
65.62%106.79M
54.66%94.23M
61.01%83.82M
51.89%73.86M
18.26%64.48M
6.42%60.93M
-1.73%52.06M
0.32%48.63M
Operating profit
248.93%49.21M
2129.27%29.63M
215.93%22.83M
174.40%15.17M
-6.33%14.10M
-84.74%1.33M
-227.94%-19.69M
-58.87%5.53M
25.60%15.05M
73.80%8.71M
1673.93%15.39M
218.66%13.44M
164.99%11.99M
124.45%5.01M
70.67%-978.00K
-70.62%-11.33M
-698.18%-18.44M
-644.46%-20.50M
-217.47%-3.33M
13.47%-6.64M
Net Profit
100.05%27.43M
337.66%25.39M
196.82%23.79M
371.83%7.32M
-14.28%13.71M
-1628.18%-10.68M
-384.30%-24.57M
-151.32%-2.69M
1638.70%16.00M
115.03%699.00K
195.97%8.64M
134.24%5.25M
104.48%920.00K
80.88%-4.65M
-102.52%-9.01M
-8.68%-15.33M
-23977.91%-20.54M
-569.22%-24.33M
-1153.79%-4.45M
-14.35%-14.11M
Balance Sheet
Current assets
39.31%747.08M
42.72%753.12M
33.97%698.40M
8.49%602.63M
-0.79%536.29M
1.51%527.68M
4.84%521.30M
20.93%555.46M
48.20%540.56M
50.99%519.82M
60.72%497.22M
42.47%459.31M
21.02%364.75M
6.99%344.26M
61.65%309.38M
68.09%322.40M
64.88%301.40M
88.92%321.77M
15.42%191.38M
22.52%191.80M
Total current liabilities
18.68%239.51M
43.59%278.11M
42.45%270.56M
69.19%236.84M
47.43%201.81M
33.13%193.68M
41.37%189.93M
13.93%139.98M
8.79%136.89M
46.30%145.48M
64.59%134.35M
27.57%122.86M
58.21%125.83M
13.60%99.44M
-3.82%81.63M
7.67%96.31M
-3.91%79.53M
11.42%87.54M
11.82%84.87M
13.11%89.45M
Total assets
10.02%1.42B
12.21%1.44B
9.38%1.41B
45.86%1.34B
41.32%1.29B
41.94%1.28B
44.66%1.29B
7.15%920.75M
19.51%914.52M
18.99%904.42M
20.40%889.91M
14.38%859.34M
2.74%765.22M
-1.49%760.09M
57.11%739.11M
56.48%751.33M
60.58%744.85M
67.31%771.60M
1.70%470.45M
3.17%480.16M
Total liabilities
1.26%859.67M
5.20%899.65M
5.34%902.34M
100.25%881.39M
93.95%848.96M
91.39%855.17M
96.82%856.58M
3.59%440.14M
2.81%437.71M
6.00%446.82M
8.14%435.20M
2.53%424.87M
6.77%425.74M
2.10%421.55M
44.22%402.44M
43.76%414.38M
53.29%398.75M
55.51%412.86M
4.33%279.05M
5.18%288.24M
Total equity
26.80%562.30M
26.18%540.72M
17.41%505.82M
-3.95%461.61M
-6.99%443.47M
-6.35%428.53M
-5.26%430.80M
10.62%480.61M
40.45%476.81M
35.17%457.60M
35.06%454.71M
28.94%434.47M
-1.91%339.48M
-5.63%338.54M
75.90%336.68M
75.57%336.96M
69.89%346.09M
83.31%358.74M
-1.89%191.40M
0.30%191.92M
Cash Flow Statement
Net operating income
66.83%58.38M
91.47%30.37M
253.17%44.05M
335.35%75.81M
91.53%34.99M
-64.55%15.86M
-61.22%12.47M
-15.57%17.41M
-14.73%18.27M
1116.82%44.74M
787.91%32.17M
279.61%20.63M
213.10%21.42M
63.89%-4.40M
167.07%3.62M
-4865.15%-11.48M
-191.65%-18.94M
-113.43%-12.19M
-234.70%-5.40M
-98.85%241.00K
Net investment
42.94%-11.32M
86.86%-1.40M
98.45%-6.16M
-55.29%-6.91M
-322.17%-19.85M
-123.50%-10.68M
-8652.95%-398.52M
34.82%-4.45M
479.64%8.93M
-52.10%-4.78M
53.61%-4.55M
-1030.13%-6.83M
-8.03%-2.35M
96.18%-3.14M
-1583.36%-9.81M
97.25%-604.00K
-195.52%-2.18M
-3779.80%-82.21M
89.96%-583.00K
-670.72%-21.95M
Net financing
-118.21%-21.62M
5.52%-4.64M
-97.82%6.34M
-20.32%-1.75M
49.78%-9.91M
58.83%-4.91M
7650.47%291.03M
-101.81%-1.45M
-333.73%-19.73M
-2246.06%-11.92M
512.18%3.75M
5677.59%80.15M
-100.35%-4.55M
-100.28%-508.00K
69.85%-911.00K
-106.88%-1.44M
16.70%-2.27M
8226.99%179.44M
-27.08%-3.02M
294.51%20.90M

FAQs

What is the total revenue of ANI Pharmaceuticals Inc?

According to ANI Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 883.37M, with a year-on-year change of 614.38M.

What are the current assets of ANI Pharmaceuticals Inc?

According to ANI Pharmaceuticals Inc's FY2025 earnings report, its current assets were 753.12M, with a year-on-year change of 42.51.

What are the total assets of ANI Pharmaceuticals Inc?

According to ANI Pharmaceuticals Inc's FY2025 earnings report, its total assets of ANI Pharmaceuticals Inc were 1.44B, with a year-on-year change of 12.14.

What are the total liabilities of ANI Pharmaceuticals Inc?

According to ANI Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of ANI Pharmaceuticals Inc were 899.65M, with a year-on-year change of 5.11.

What is the total equity of ANI Pharmaceuticals Inc?

According to ANI Pharmaceuticals Inc's FY2025 earnings report, its total equity of ANI Pharmaceuticals Inc was 540.72M, with a year-on-year change of 26.18.

What is the net operating income of ANI Pharmaceuticals Inc?

According to ANI Pharmaceuticals Inc's FY2025 earnings report, its net operating income of ANI Pharmaceuticals Inc was 83.33M, with a year-on-year change of 470.05.

What is the net investment of ANI Pharmaceuticals Inc?

According to ANI Pharmaceuticals Inc's FY2025 earnings report, its net investment of ANI Pharmaceuticals Inc was -34.32M, with a year-on-year change of 91.52.

What is the net financing of ANI Pharmaceuticals Inc?

According to ANI Pharmaceuticals Inc's FY2025 earnings report, its net financing of ANI Pharmaceuticals Inc was -9.94M, with a year-on-year change of -103.75.

What is the Earnings Per Share (EPS) of ANI Pharmaceuticals Inc?

According to ANI Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 3.50, with a year-on-year change of 435.75.

What is the net income of ANI Pharmaceuticals Inc?

According to ANI Pharmaceuticals Inc's FY2025 earnings report, its net income was 70.22M, with a year-on-year change of 448.52.

What is the net margin of ANI Pharmaceuticals Inc?

According to ANI Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was 8.87, with a year-on-year change of 394.15.

What is the gross margin of ANI Pharmaceuticals Inc?

According to ANI Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 51.01, with a year-on-year change of 5.73.

What is the debt-to-asset ratio of ANI Pharmaceuticals Inc?

According to ANI Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 42.85, with a year-on-year change of -11.81.

What is the Return on Equity (ROE) of ANI Pharmaceuticals Inc?

According to ANI Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was 14.87, with a year-on-year change of 408.68.

What is the Return on Assets (ROA) of ANI Pharmaceuticals Inc?

According to ANI Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was 5.75, with a year-on-year change of 439.75.

What is the operating profit of ANI Pharmaceuticals Inc?

According to ANI Pharmaceuticals Inc's FY2025 earnings report, its operating profit was 83.33M, with a year-on-year change of 470.05.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy